Profile

MPH, Boston University School of Public Health





ARV Price Project
10/01/2008 - 03/31/2011 (PI)
NAM Dep for Internationa

Utilization of an Electronic Platform to Monitor the Anti-Malarial Market and Guide Access Initiativ
11/01/2008 - 12/31/2010 (PI)
Medicine for Malaria Ventures


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bärnighausen T, Kyle M, Salomon JA, Waning B. Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy Plan. 2012 Sep; 27(6):467-76. PMID: 21914713; PMCID: PMC3431498; DOI: 10.1093/heapol/czr058;
     
  2. Waning B, Diedrichsen E, Jambert E, Bärnighausen T, Li Y, Pouw M, Moon S. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr. 2010; 10:74.View Related Profiles. PMID: 20950492; PMCID: PMC2964660; DOI: 10.1186/1471-2431-10-74;
     
  3. Waning B, Diedrichsen E, Moon S. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc. 2010; 13:35. PMID: 20840741; PMCID: PMC2944814; DOI: 10.1186/1758-2652-13-35;
     
  4. Waning B, Maddix J, Soucy L. Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan. BMC Health Serv Res. 2010; 10:205. PMID: 20626904; PMCID: PMC2914726; DOI: 10.1186/1472-6963-10-205;
     
  5. Waning B, Kyle M, Diedrichsen E, Soucy L, Hochstadt J, Bärnighausen T, Moon S. Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Global Health. 2010; 6:9. PMID: 20500827; PMCID: PMC2883977; DOI: 10.1186/1744-8603-6-9;
     
  6. Waning B, Maddix J, Tripodis Y, Laing R, Leufkens HG, Gokhale M. Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan. Int J Equity Health. 2009; 8:43.View Related Profiles. PMID: 20003422; PMCID: PMC2803474; DOI: 10.1186/1475-9276-8-43;
     
  7. Waning B, Kaplan W, King AC, Lawrence DA, Leufkens HG, Fox MP. Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. Bull World Health Organ. 2009 Jul; 87(7):520-8.View Related Profiles. PMID: 19649366; PMCID: PMC2704041; DOI: 10.2471/BLT.08.058925;
     
  8. Waning BJ. The great medicines scandal: access is not just about cost. BMJ. 2006 Jul 1; 333(7557):44. PMID: 16809717; PMCID: PMC1488803
     
  9. Laing R, Waning B, Gray A, Ford N, 't Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003 May 17; 361(9370):1723-9.View Related Profiles. PMID: 12767751
     
  10. Waning BJ, McCloskey WW. Confidence about an odds ratio. Am J Health Syst Pharm. 1999 Oct 1; 56(19):1989-90. PMID: 10554921
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: